Sparavelli, R.; Bruno, R.; Celi, A.; Sbrana, A.; Petrini, I.; Chella, A.; Ugolini, C.; Alì, G.
Prevalence of Histological Transformation in First-Line Osimertinib Non-Small Cell Lung Cancers: Case Series and Literature Review. Int. J. Mol. Sci. 2025, 26, 10462.
https://doi.org/10.3390/ijms262110462
AMA Style
Sparavelli R, Bruno R, Celi A, Sbrana A, Petrini I, Chella A, Ugolini C, Alì G.
Prevalence of Histological Transformation in First-Line Osimertinib Non-Small Cell Lung Cancers: Case Series and Literature Review. International Journal of Molecular Sciences. 2025; 26(21):10462.
https://doi.org/10.3390/ijms262110462
Chicago/Turabian Style
Sparavelli, Rebecca, Rossella Bruno, Alessandra Celi, Andrea Sbrana, Iacopo Petrini, Antonio Chella, Clara Ugolini, and Greta Alì.
2025. "Prevalence of Histological Transformation in First-Line Osimertinib Non-Small Cell Lung Cancers: Case Series and Literature Review" International Journal of Molecular Sciences 26, no. 21: 10462.
https://doi.org/10.3390/ijms262110462
APA Style
Sparavelli, R., Bruno, R., Celi, A., Sbrana, A., Petrini, I., Chella, A., Ugolini, C., & Alì, G.
(2025). Prevalence of Histological Transformation in First-Line Osimertinib Non-Small Cell Lung Cancers: Case Series and Literature Review. International Journal of Molecular Sciences, 26(21), 10462.
https://doi.org/10.3390/ijms262110462